Parallel Joint Scientific Consultations Under the EU HTA Regulation: What Have We Learned from the First Procedures?

About this session

Issue Joint Scientific Consultations (JSCs) are designed to facilitate early dialogue between health technology developers (HTDs), HTA bodies, regulators, patients and healthcare professionals. By enabling discussion on evidence generation plans early on, JSCs aim to support more informed decision-making and contribute to the generation of evidence relevant to multiple stakeholders.

Speakers

• MR

  Mihai Rotaru

  EFPIA

  Moderator

• 

  Karina Hansen

  NOVARTIS

  Panelist

• SS

  Stephanie Said

  Panelist

• 

  Michael Berntgen

  Head of Evidence Generation Department · European Medicines Agency

  Panelist